Chromocell Therapeutics (Chromocell Therapeutics) Beginning Cash Position : $0.10 Mil (As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Chromocell Therapeutics Beginning Cash Position?

Chromocell Therapeutics's Beginning Cash Position for the quarter that ended in Mar. 2024 was $0.10 Mil.

Chromocell Therapeutics's quarterly Beginning Cash Position declined from Sep. 2023 ($0.08 Mil) to Dec. 2023 ($0.02 Mil) but then increased from Dec. 2023 ($0.02 Mil) to Mar. 2024 ($0.10 Mil).

Chromocell Therapeutics's annual Beginning Cash Position declined from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($-0.00 Mil) but then increased from Dec. 2022 ($-0.00 Mil) to Dec. 2023 ($0.06 Mil).

Chromocell Therapeutics Beginning Cash Position Historical Data

The historical data trend for Chromocell Therapeutics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chromocell Therapeutics Beginning Cash Position Chart

Chromocell Therapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

0.06

Chromocell Therapeutics Quarterly Data
	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial							0.06	0.05	0.08	0.02	0.10

Chromocell Therapeutics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Chromocell Therapeutics Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Chromocell Therapeutics's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Chromocell Therapeutics (Chromocell Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chromocell Therapeutics Corp (AMEX:CHRO) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Chromocell Therapeutics Corp is a clinical-stage biotech company focused on developing and commercializing new therapeutics to alleviate pain. Its clinical focus is to selectively target the sodium ion-channel known as "NaV1.7", as well as other receptors in the NaV family. NaV1.7 has been genetically validated as a pain receptor in human physiology.